Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery
Lars Sjöström(Sahlgrenska University Hospital), Hans Wedel(Sahlgrenska University Hospital), Kristina Narbro, Claude Bouchard(Pennington Biomedical Research Center), Marianne Sullivan(William Paterson University), Markku Peltonen(Finnish Institute for Health and Welfare), Bo Larsson(University of Gothenburg), Jarl Torgerson(Norra Älvsborgs Länssjukhus), S Dahlgren, Anna‐Karin Lindroos(MRC Human Nutrition Research), Björn Carlsson
Cited by 4,461
Related Papers
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
|JNCI Journal of the National Cancer Institute|1993|15.9k
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
|The Lancet|1998|5.8k
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
|The Lancet|2002|5.4k
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
|New England Journal of Medicine|2007|4.6k